RenovoRx announces publication of data related to TAMP platform
PremiumThe FlyRenovoRx announces publication of data related to TAMP platform
4M ago
RenovoRx announces acceptance for publication in The Oncologist
Premium
The Fly
RenovoRx announces acceptance for publication in The Oncologist
4M ago
RenovoRx announces UNMC is enrolling patients with LAPC for Phase III trial
Premium
The Fly
RenovoRx announces UNMC is enrolling patients with LAPC for Phase III trial
5M ago
RenovoRx: Efficacy/drug delivery potential of TAMP improve cancer therapy
PremiumThe FlyRenovoRx: Efficacy/drug delivery potential of TAMP improve cancer therapy
6M ago
Biopharmaceutical Challenger Renovorx: Navigating Uncertainty and Financial Risks in Drug Development
Premium
Company Announcements
Biopharmaceutical Challenger Renovorx: Navigating Uncertainty and Financial Risks in Drug Development
6M ago
RenovoRx files to sell 6.96M shares of common stock for holders
Premium
The Fly
RenovoRx files to sell 6.96M shares of common stock for holders
7M ago
RenovoRx to present initial interim analysis of Phase III TIGeR-PaC trial
PremiumThe FlyRenovoRx to present initial interim analysis of Phase III TIGeR-PaC trial
7M ago
RNXT Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
RNXT Earnings this Week: How Will it Perform?
8M ago
RenovoRx promotes Leesa Gentry to chief clinical officer
Premium
The Fly
RenovoRx promotes Leesa Gentry to chief clinical officer
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100